Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:25 PM
Ignite Modification Date:
2025-12-24 @ 4:25 PM
NCT ID:
NCT00000766
Eligibility Criteria:
Inclusion Criteria
Required:
* At least 28 days of prior foscarnet or ganciclovir.
Concurrent Medication:
Allowed:
* G-CSF.
Recommended:
* Antiretroviral therapy.
Patients must have:
* HIV infection or AIDS.
* Active CMV retinitis after 28 or more days of either foscarnet or ganciclovir therapy.
* At least one lesion with one-quarter disk area or more that can be photographed.
* Visual acuity of 3 or more letters on ETDRS chart (5/200 Snellen) in an affected eye.
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms and conditions are excluded:
* Media opacity severe enough to preclude visualization of both fundi.
* Retinal detachment not scheduled for surgical repair.
Patients with the following prior conditions are excluded:
* History of intolerance to ganciclovir or foscarnet sufficient to contraindicate use.
* History of combination foscarnet/ganciclovir therapy.
Active drug or alcohol abuse sufficient to prevent compliance.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00000766
Study Brief:
Protocol Section:
NCT00000766